

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | aminoglycoside antibiotic metabolic process (GO:0030647) | 7.36041818 |
| 2 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.65877498 |
| 3 | maintenance of protein location in nucleus (GO:0051457) | 6.56947721 |
| 4 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 6.55501067 |
| 5 | cytidine metabolic process (GO:0046087) | 6.43140127 |
| 6 | cytidine catabolic process (GO:0006216) | 6.43140127 |
| 7 | cytidine deamination (GO:0009972) | 6.43140127 |
| 8 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 6.00333174 |
| 9 | somite rostral/caudal axis specification (GO:0032525) | 5.84005631 |
| 10 | regulation of cilium movement (GO:0003352) | 5.82117260 |
| 11 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 5.81634165 |
| 12 | regulation of response to osmotic stress (GO:0047484) | 5.67685206 |
| 13 | regulation of skeletal muscle contraction (GO:0014819) | 5.63436440 |
| 14 | coenzyme catabolic process (GO:0009109) | 5.53785786 |
| 15 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 5.50164639 |
| 16 | muscle filament sliding (GO:0030049) | 5.38440078 |
| 17 | actin-myosin filament sliding (GO:0033275) | 5.38440078 |
| 18 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.37046072 |
| 19 | quinone metabolic process (GO:1901661) | 5.28483081 |
| 20 | negative regulation of epidermis development (GO:0045683) | 5.26412294 |
| 21 | cullin deneddylation (GO:0010388) | 5.25585151 |
| 22 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 5.15119329 |
| 23 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.14783665 |
| 24 | histone H4-K8 acetylation (GO:0043982) | 5.11192658 |
| 25 | histone H4-K5 acetylation (GO:0043981) | 5.11192658 |
| 26 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.05634811 |
| 27 | protein deneddylation (GO:0000338) | 5.01372070 |
| 28 | regulation of telomere maintenance via telomerase (GO:0032210) | 4.97175314 |
| 29 | regulation of MHC class I biosynthetic process (GO:0045343) | 4.91946599 |
| 30 | muscle organ morphogenesis (GO:0048644) | 4.91932980 |
| 31 | rRNA transcription (GO:0009303) | 4.82564281 |
| 32 | rRNA methylation (GO:0031167) | 4.76285195 |
| 33 | negative regulation of telomerase activity (GO:0051974) | 4.72773687 |
| 34 | histone H4-K12 acetylation (GO:0043983) | 4.66818475 |
| 35 | mitotic sister chromatid segregation (GO:0000070) | 4.59681903 |
| 36 | protein localization to kinetochore (GO:0034501) | 4.56352924 |
| 37 | phenol-containing compound catabolic process (GO:0019336) | 4.46162268 |
| 38 | behavioral response to nicotine (GO:0035095) | 4.39381187 |
| 39 | actin-mediated cell contraction (GO:0070252) | 4.36229758 |
| 40 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.35026730 |
| 41 | regulation of relaxation of muscle (GO:1901077) | 4.33564039 |
| 42 | interferon-gamma production (GO:0032609) | 4.29603799 |
| 43 | microtubule severing (GO:0051013) | 4.27416554 |
| 44 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 4.25920923 |
| 45 | protein polyglutamylation (GO:0018095) | 4.17647999 |
| 46 | negative regulation of telomere maintenance (GO:0032205) | 4.15225397 |
| 47 | hormone catabolic process (GO:0042447) | 4.15100097 |
| 48 | nucleoside transmembrane transport (GO:1901642) | 4.13964188 |
| 49 | notochord development (GO:0030903) | 4.12861214 |
| 50 | mitochondrion distribution (GO:0048311) | 4.12299641 |
| 51 | rRNA modification (GO:0000154) | 4.10784853 |
| 52 | negative regulation of epidermal cell differentiation (GO:0045605) | 4.07268427 |
| 53 | skeletal muscle contraction (GO:0003009) | 4.05921707 |
| 54 | response to dietary excess (GO:0002021) | 4.01553781 |
| 55 | histone H4-K16 acetylation (GO:0043984) | 3.74850341 |
| 56 | cellular modified amino acid catabolic process (GO:0042219) | 3.74038632 |
| 57 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.73060260 |
| 58 | tricarboxylic acid cycle (GO:0006099) | 3.66758651 |
| 59 | response to pheromone (GO:0019236) | 3.59322944 |
| 60 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.58676313 |
| 61 | regulation of microtubule-based movement (GO:0060632) | 3.56154757 |
| 62 | maintenance of protein localization in organelle (GO:0072595) | 3.55516478 |
| 63 | DNA replication checkpoint (GO:0000076) | 3.48616886 |
| 64 | sister chromatid segregation (GO:0000819) | 3.47892871 |
| 65 | response to inactivity (GO:0014854) | 3.43436977 |
| 66 | transcription from mitochondrial promoter (GO:0006390) | 3.42664178 |
| 67 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.38795223 |
| 68 | primitive streak formation (GO:0090009) | 3.38762097 |
| 69 | regulation of membrane repolarization (GO:0060306) | 3.35481551 |
| 70 | regulation of G0 to G1 transition (GO:0070316) | 3.34474392 |
| 71 | biotin metabolic process (GO:0006768) | 3.33029329 |
| 72 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.32674299 |
| 73 | nucleoside transport (GO:0015858) | 3.31447604 |
| 74 | epoxygenase P450 pathway (GO:0019373) | 3.30028608 |
| 75 | protein localization to chromosome, centromeric region (GO:0071459) | 3.29379446 |
| 76 | GDP-mannose metabolic process (GO:0019673) | 3.27322919 |
| 77 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.27208456 |
| 78 | synaptic transmission, cholinergic (GO:0007271) | 3.26947769 |
| 79 | neuronal action potential propagation (GO:0019227) | 3.26319435 |
| 80 | positive regulation of protein deacetylation (GO:0090312) | 3.23435358 |
| 81 | regulation of translation in response to stress (GO:0043555) | 3.22300327 |
| 82 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.20181426 |
| 83 | detection of temperature stimulus (GO:0016048) | 3.17527347 |
| 84 | regulation of telomerase activity (GO:0051972) | 3.16937790 |
| 85 | striated muscle contraction (GO:0006941) | 3.16907734 |
| 86 | myofibril assembly (GO:0030239) | 3.16821518 |
| 87 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 3.13209927 |
| 88 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.12592413 |
| 89 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.12592413 |
| 90 | icosanoid secretion (GO:0032309) | 3.12171096 |
| 91 | arachidonic acid secretion (GO:0050482) | 3.12171096 |
| 92 | glycolytic process (GO:0006096) | 3.10087722 |
| 93 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.10023504 |
| 94 | cardiovascular system development (GO:0072358) | 3.06457889 |
| 95 | sarcomere organization (GO:0045214) | 3.06229462 |
| 96 | proline transport (GO:0015824) | 3.05558246 |
| 97 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.05012938 |
| 98 | membrane depolarization during action potential (GO:0086010) | 3.02023730 |
| 99 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 3.01511948 |
| 100 | protein neddylation (GO:0045116) | 3.01147123 |
| 101 | neuromuscular synaptic transmission (GO:0007274) | 2.99117007 |
| 102 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.98015474 |
| 103 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.98015474 |
| 104 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 2.96884694 |
| 105 | regulation of intracellular estrogen receptor signaling pathway (GO:0033146) | 2.96635993 |
| 106 | ubiquinone biosynthetic process (GO:0006744) | 2.96632971 |
| 107 | regulation of cell communication by electrical coupling (GO:0010649) | 2.96181071 |
| 108 | cofactor catabolic process (GO:0051187) | 2.96172692 |
| 109 | regulation of telomere maintenance (GO:0032204) | 2.96062164 |
| 110 | cofactor transport (GO:0051181) | 2.95754066 |
| 111 | thyroid hormone generation (GO:0006590) | 2.94991711 |
| 112 | melanosome transport (GO:0032402) | 2.93338275 |
| 113 | mitochondrion localization (GO:0051646) | 2.92405441 |
| 114 | phagocytosis, recognition (GO:0006910) | 2.91399927 |
| 115 | apoptotic DNA fragmentation (GO:0006309) | 2.91250593 |
| 116 | bone trabecula formation (GO:0060346) | 2.91147088 |
| 117 | pseudouridine synthesis (GO:0001522) | 2.90688805 |
| 118 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.89375441 |
| 119 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.89375441 |
| 120 | NADH dehydrogenase complex assembly (GO:0010257) | 2.89375441 |
| 121 | creatine metabolic process (GO:0006600) | 2.87928795 |
| 122 | retinoic acid receptor signaling pathway (GO:0048384) | 2.86364080 |
| 123 | nucleobase catabolic process (GO:0046113) | 2.86228977 |
| 124 | regulation of cardiac muscle cell apoptotic process (GO:0010665) | 2.86051561 |
| 125 | receptor recycling (GO:0001881) | 2.84930207 |
| 126 | protein complex biogenesis (GO:0070271) | 2.84576262 |
| 127 | positive regulation of protein homodimerization activity (GO:0090073) | 2.83607696 |
| 128 | establishment of melanosome localization (GO:0032401) | 2.81181406 |
| 129 | actin filament-based movement (GO:0030048) | 2.80772301 |
| 130 | heterochromatin organization (GO:0070828) | 2.79729536 |
| 131 | positive regulation of defense response to virus by host (GO:0002230) | 2.79219060 |
| 132 | intestinal epithelial cell development (GO:0060576) | 2.79047458 |
| 133 | DNA deamination (GO:0045006) | 2.78090452 |
| 134 | adenosine metabolic process (GO:0046085) | 2.77709296 |
| 135 | negative regulation of appetite (GO:0032099) | 2.76590275 |
| 136 | negative regulation of response to food (GO:0032096) | 2.76590275 |
| 137 | myotube cell development (GO:0014904) | 2.73400755 |
| 138 | inositol phosphate catabolic process (GO:0071545) | 2.72892801 |
| 139 | regulation of action potential (GO:0098900) | 2.72854717 |
| 140 | calcium ion import (GO:0070509) | 2.70978935 |
| 141 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.68255358 |
| 142 | neuronal action potential (GO:0019228) | 2.67849748 |
| 143 | negative regulation of protein localization to cell surface (GO:2000009) | 2.66288346 |
| 144 | gamma-aminobutyric acid transport (GO:0015812) | 2.66156734 |
| 145 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.65333766 |
| 146 | skeletal muscle fiber development (GO:0048741) | 2.64457998 |
| 147 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.64139759 |
| 148 | ubiquinone metabolic process (GO:0006743) | 2.62023896 |
| 149 | nitric oxide mediated signal transduction (GO:0007263) | 2.59585919 |
| 150 | response to muscle activity (GO:0014850) | 2.59461560 |
| 151 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.59312478 |
| 152 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.59087184 |
| 153 | regulation of female receptivity (GO:0045924) | 2.58730022 |
| 154 | muscle fiber development (GO:0048747) | 2.58569321 |
| 155 | negative regulation of heart rate (GO:0010459) | 2.58318127 |
| 156 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.55760604 |
| 157 | detection of light stimulus involved in visual perception (GO:0050908) | 2.55760604 |
| 158 | regulation of actin filament-based movement (GO:1903115) | 2.55159387 |
| 159 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.54023849 |
| 160 | postsynaptic membrane organization (GO:0001941) | 2.53814554 |
| 161 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.50726811 |
| 162 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.50634691 |
| 163 | regulation of hexokinase activity (GO:1903299) | 2.50423163 |
| 164 | regulation of glucokinase activity (GO:0033131) | 2.50423163 |
| 165 | muscle contraction (GO:0006936) | 2.50072081 |
| 166 | pyrimidine-containing compound catabolic process (GO:0072529) | 2.49768491 |
| 167 | regulation of striated muscle contraction (GO:0006942) | 2.47800006 |
| 168 | somite development (GO:0061053) | 2.44934258 |
| 169 | regulation of sarcomere organization (GO:0060297) | 2.44270527 |
| 170 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.43293208 |
| 171 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.42452294 |
| 172 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.42077773 |
| 173 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.40090602 |
| 174 | C4-dicarboxylate transport (GO:0015740) | 2.38857323 |
| 175 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.38313634 |
| 176 | action potential (GO:0001508) | 2.37072418 |
| 177 | quinone biosynthetic process (GO:1901663) | 2.36818718 |
| 178 | activated T cell proliferation (GO:0050798) | 2.35346727 |
| 179 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.35153499 |
| 180 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.33560839 |
| 181 | cellular ketone body metabolic process (GO:0046950) | 2.33141278 |
| 182 | muscle system process (GO:0003012) | 2.33012934 |
| 183 | adaptation of signaling pathway (GO:0023058) | 2.31362361 |
| 184 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.31338969 |
| 185 | positive regulation of mitochondrial fission (GO:0090141) | 2.30851091 |
| 186 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.30404387 |
| 187 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.27129021 |
| 188 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.27129021 |
| 189 | platelet dense granule organization (GO:0060155) | 2.26669151 |
| 190 | skeletal muscle tissue regeneration (GO:0043403) | 2.26261835 |
| 191 | negative regulation of muscle contraction (GO:0045932) | 2.25987501 |
| 192 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.25779501 |
| 193 | polyketide metabolic process (GO:0030638) | 11.5976202 |
| 194 | doxorubicin metabolic process (GO:0044598) | 11.5976202 |
| 195 | daunorubicin metabolic process (GO:0044597) | 11.5976202 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 8.97602200 |
| 2 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 6.00377953 |
| 3 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 5.78026865 |
| 4 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 5.78026865 |
| 5 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 5.78026865 |
| 6 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.22065841 |
| 7 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 3.18909829 |
| 8 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.94624006 |
| 9 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.80980634 |
| 10 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.73754549 |
| 11 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.73333228 |
| 12 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.73273141 |
| 13 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.69705784 |
| 14 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.67043706 |
| 15 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.62648193 |
| 16 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.58629721 |
| 17 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.30009889 |
| 18 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.29220881 |
| 19 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.24866514 |
| 20 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.21300884 |
| 21 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.20226493 |
| 22 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 2.08574998 |
| 23 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.08566190 |
| 24 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.04873051 |
| 25 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 2.04135297 |
| 26 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.92789165 |
| 27 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.89895002 |
| 28 | VDR_22108803_ChIP-Seq_LS180_Human | 1.88622556 |
| 29 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.80232194 |
| 30 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.79267613 |
| 31 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.77990332 |
| 32 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.72977662 |
| 33 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.71298348 |
| 34 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.67322252 |
| 35 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67082965 |
| 36 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.66501468 |
| 37 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.64925832 |
| 38 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.64031652 |
| 39 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.59628628 |
| 40 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.56598852 |
| 41 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.54594929 |
| 42 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.54192484 |
| 43 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.53313718 |
| 44 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.52528786 |
| 45 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.50676023 |
| 46 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.49310248 |
| 47 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.48954134 |
| 48 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.48937582 |
| 49 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.48092422 |
| 50 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.46851619 |
| 51 | P300_19829295_ChIP-Seq_ESCs_Human | 1.46677038 |
| 52 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.46235478 |
| 53 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.41314234 |
| 54 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.41298219 |
| 55 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.39033847 |
| 56 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.39033847 |
| 57 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.37782067 |
| 58 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.37549018 |
| 59 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.36894747 |
| 60 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.36809490 |
| 61 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.36351189 |
| 62 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.36187362 |
| 63 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.35907187 |
| 64 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.35071117 |
| 65 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.35030349 |
| 66 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.34926184 |
| 67 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.34725132 |
| 68 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.33280984 |
| 69 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.32448435 |
| 70 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.32360790 |
| 71 | FUS_26573619_Chip-Seq_HEK293_Human | 1.32268136 |
| 72 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.31321529 |
| 73 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.31231856 |
| 74 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.30975266 |
| 75 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.30685711 |
| 76 | * TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.29687478 |
| 77 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.27640589 |
| 78 | AR_25329375_ChIP-Seq_VCAP_Human | 1.27587888 |
| 79 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.25293883 |
| 80 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.25293883 |
| 81 | EWS_26573619_Chip-Seq_HEK293_Human | 1.24825610 |
| 82 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.24033452 |
| 83 | * HTT_18923047_ChIP-ChIP_STHdh_Human | 1.22643586 |
| 84 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.22307812 |
| 85 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.21860348 |
| 86 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.21666138 |
| 87 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.21518339 |
| 88 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.21345316 |
| 89 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.20232909 |
| 90 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.19906541 |
| 91 | TCF4_23295773_ChIP-Seq_U87_Human | 1.19417491 |
| 92 | STAT3_23295773_ChIP-Seq_U87_Human | 1.17337923 |
| 93 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.15238957 |
| 94 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.14851672 |
| 95 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.14846836 |
| 96 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14677509 |
| 97 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.13309886 |
| 98 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.12312022 |
| 99 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.11390939 |
| 100 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.10766143 |
| 101 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.09827967 |
| 102 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.09662948 |
| 103 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.08069467 |
| 104 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.07947993 |
| 105 | * GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.07695149 |
| 106 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.07573561 |
| 107 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.06854729 |
| 108 | NCOR_22424771_ChIP-Seq_293T_Human | 1.06815170 |
| 109 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.06800781 |
| 110 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.06420661 |
| 111 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 1.06081023 |
| 112 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.05963216 |
| 113 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.05727151 |
| 114 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.04031987 |
| 115 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.03766378 |
| 116 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.03708827 |
| 117 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.03621141 |
| 118 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.03093996 |
| 119 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.02776928 |
| 120 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.02468990 |
| 121 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.02377779 |
| 122 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.02114981 |
| 123 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.01150112 |
| 124 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.01005515 |
| 125 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.00646685 |
| 126 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.00358590 |
| 127 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.00358590 |
| 128 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.00254392 |
| 129 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.99888763 |
| 130 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.99759319 |
| 131 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.99194588 |
| 132 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.98982356 |
| 133 | AR_20517297_ChIP-Seq_VCAP_Human | 0.98276244 |
| 134 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.98033648 |
| 135 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.96989772 |
| 136 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.96627824 |
| 137 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.96390266 |
| 138 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.96122333 |
| 139 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.95702997 |
| 140 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.95129485 |
| 141 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95129485 |
| 142 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94988958 |
| 143 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.94606318 |
| 144 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.94534933 |
| 145 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.94459729 |
| 146 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.94427436 |
| 147 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.93886350 |
| 148 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.93597372 |
| 149 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.93282895 |
| 150 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.92140591 |
| 151 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.91949292 |
| 152 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.91874049 |
| 153 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.91687157 |
| 154 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.91609337 |
| 155 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.90567643 |
| 156 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.89561766 |
| 157 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.89499261 |
| 158 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.89253735 |
| 159 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.88474286 |
| 160 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.88277182 |
| 161 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.88053248 |
| 162 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.87826567 |
| 163 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.87500416 |
| 164 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.87473144 |
| 165 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.87314869 |
| 166 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.87116116 |
| 167 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.86545242 |
| 168 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.85929213 |
| 169 | STAT3_18555785_ChIP-Seq_MESCs_Mouse | 0.84276411 |
| 170 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.84031969 |
| 171 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83406326 |
| 172 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.82740938 |
| 173 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.81514182 |
| 174 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.80432691 |
| 175 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.79998390 |
| 176 | SETDB1_19884257_ChIP-Seq_MESCs_Mouse | 0.77726348 |
| 177 | * SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.77378717 |
| 178 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.76618392 |
| 179 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.76157089 |
| 180 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.74131756 |
| 181 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.73120983 |
| 182 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.71931327 |
| 183 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.71847033 |
| 184 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.71632684 |
| 185 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.70368422 |
| 186 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.70242745 |
| 187 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.70207366 |
| 188 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.70126572 |
| 189 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.69697830 |
| 190 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.69263262 |
| 191 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.68760482 |
| 192 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.68682146 |
| 193 | SOX3_22085726_ChIP-Seq_NPCs_Mouse | 0.68267149 |
| 194 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.68246935 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003011_delayed_dark_adaptation | 4.52699164 |
| 2 | MP0006292_abnormal_olfactory_placode | 3.85767408 |
| 3 | MP0002332_abnormal_exercise_endurance | 3.69699436 |
| 4 | MP0004264_abnormal_extraembryonic_tissu | 3.56718926 |
| 5 | MP0000749_muscle_degeneration | 3.41281500 |
| 6 | MP0003646_muscle_fatigue | 3.35444858 |
| 7 | MP0004858_abnormal_nervous_system | 3.31860073 |
| 8 | MP0003122_maternal_imprinting | 3.19070533 |
| 9 | MP0006035_abnormal_mitochondrial_morpho | 3.13510012 |
| 10 | MP0005499_abnormal_olfactory_system | 3.02909656 |
| 11 | MP0005394_taste/olfaction_phenotype | 3.02909656 |
| 12 | MP0005075_abnormal_melanosome_morpholog | 2.93861571 |
| 13 | MP0003183_abnormal_peptide_metabolism | 2.62880254 |
| 14 | MP0002254_reproductive_system_inflammat | 2.56160274 |
| 15 | MP0002837_dystrophic_cardiac_calcinosis | 2.36498542 |
| 16 | MP0004084_abnormal_cardiac_muscle | 2.35197947 |
| 17 | MP0002127_abnormal_cardiovascular_syste | 2.33971502 |
| 18 | MP0003890_abnormal_embryonic-extraembry | 2.24470006 |
| 19 | MP0002653_abnormal_ependyma_morphology | 2.23603484 |
| 20 | MP0008057_abnormal_DNA_replication | 2.20057862 |
| 21 | MP0003121_genomic_imprinting | 2.17961537 |
| 22 | MP0004215_abnormal_myocardial_fiber | 2.15280922 |
| 23 | MP0000750_abnormal_muscle_regeneration | 2.15179119 |
| 24 | MP0006036_abnormal_mitochondrial_physio | 2.14903338 |
| 25 | MP0003137_abnormal_impulse_conducting | 2.08443482 |
| 26 | MP0002269_muscular_atrophy | 2.02806642 |
| 27 | MP0004036_abnormal_muscle_relaxation | 2.01120643 |
| 28 | MP0001986_abnormal_taste_sensitivity | 1.99541436 |
| 29 | MP0005266_abnormal_metabolism | 1.90835874 |
| 30 | MP0005330_cardiomyopathy | 1.80259654 |
| 31 | MP0002102_abnormal_ear_morphology | 1.79459528 |
| 32 | MP0000751_myopathy | 1.78079915 |
| 33 | MP0002638_abnormal_pupillary_reflex | 1.74461094 |
| 34 | MP0004957_abnormal_blastocyst_morpholog | 1.74033615 |
| 35 | MP0002822_catalepsy | 1.72798437 |
| 36 | MP0006276_abnormal_autonomic_nervous | 1.63841810 |
| 37 | MP0004087_abnormal_muscle_fiber | 1.62208173 |
| 38 | MP0005646_abnormal_pituitary_gland | 1.60463992 |
| 39 | MP0004147_increased_porphyrin_level | 1.59611025 |
| 40 | MP0002106_abnormal_muscle_physiology | 1.57068303 |
| 41 | MP0004043_abnormal_pH_regulation | 1.55465844 |
| 42 | MP0001968_abnormal_touch/_nociception | 1.53445962 |
| 43 | MP0000759_abnormal_skeletal_muscle | 1.52517736 |
| 44 | MP0005620_abnormal_muscle_contractility | 1.50660130 |
| 45 | MP0004145_abnormal_muscle_electrophysio | 1.49063468 |
| 46 | MP0005257_abnormal_intraocular_pressure | 1.48628819 |
| 47 | MP0002972_abnormal_cardiac_muscle | 1.47637572 |
| 48 | MP0000678_abnormal_parathyroid_gland | 1.44160027 |
| 49 | MP0008877_abnormal_DNA_methylation | 1.42976430 |
| 50 | MP0005645_abnormal_hypothalamus_physiol | 1.42338065 |
| 51 | MP0002272_abnormal_nervous_system | 1.42028986 |
| 52 | MP0005423_abnormal_somatic_nervous | 1.39443770 |
| 53 | MP0005551_abnormal_eye_electrophysiolog | 1.38222473 |
| 54 | MP0009745_abnormal_behavioral_response | 1.36997035 |
| 55 | MP0008872_abnormal_physiological_respon | 1.35769946 |
| 56 | MP0002876_abnormal_thyroid_physiology | 1.35053635 |
| 57 | MP0005084_abnormal_gallbladder_morpholo | 1.33495348 |
| 58 | MP0006082_CNS_inflammation | 1.32211954 |
| 59 | MP0001984_abnormal_olfaction | 1.31761206 |
| 60 | MP0005369_muscle_phenotype | 1.31335868 |
| 61 | MP0000372_irregular_coat_pigmentation | 1.30462551 |
| 62 | MP0002088_abnormal_embryonic_growth/wei | 1.29431283 |
| 63 | MP0003984_embryonic_growth_retardation | 1.28603723 |
| 64 | MP0003879_abnormal_hair_cell | 1.28026173 |
| 65 | MP0001672_abnormal_embryogenesis/_devel | 1.27766348 |
| 66 | MP0005380_embryogenesis_phenotype | 1.27766348 |
| 67 | MP0000230_abnormal_systemic_arterial | 1.24380301 |
| 68 | MP0002733_abnormal_thermal_nociception | 1.24299054 |
| 69 | MP0003938_abnormal_ear_development | 1.24295702 |
| 70 | MP0003724_increased_susceptibility_to | 1.22381805 |
| 71 | MP0004085_abnormal_heartbeat | 1.21450550 |
| 72 | MP0002277_abnormal_respiratory_mucosa | 1.20708641 |
| 73 | MP0002736_abnormal_nociception_after | 1.19490532 |
| 74 | MP0000343_altered_response_to | 1.18386449 |
| 75 | MP0001970_abnormal_pain_threshold | 1.17802164 |
| 76 | MP0001529_abnormal_vocalization | 1.16860296 |
| 77 | MP0003880_abnormal_central_pattern | 1.16845212 |
| 78 | MP0008789_abnormal_olfactory_epithelium | 1.16298167 |
| 79 | MP0002734_abnormal_mechanical_nocicepti | 1.15477178 |
| 80 | MP0003635_abnormal_synaptic_transmissio | 1.13537088 |
| 81 | MP0001905_abnormal_dopamine_level | 1.12084270 |
| 82 | MP0003221_abnormal_cardiomyocyte_apopto | 1.11770079 |
| 83 | MP0003705_abnormal_hypodermis_morpholog | 1.11592478 |
| 84 | MP0002970_abnormal_white_adipose | 1.09847036 |
| 85 | MP0010630_abnormal_cardiac_muscle | 1.09176166 |
| 86 | MP0002064_seizures | 1.09150609 |
| 87 | MP0008775_abnormal_heart_ventricle | 1.09028270 |
| 88 | MP0002735_abnormal_chemical_nociception | 1.06352358 |
| 89 | MP0005253_abnormal_eye_physiology | 1.04870811 |
| 90 | MP0004885_abnormal_endolymph | 1.04313694 |
| 91 | MP0008961_abnormal_basal_metabolism | 1.04105775 |
| 92 | MP0002067_abnormal_sensory_capabilities | 1.03328533 |
| 93 | MP0005167_abnormal_blood-brain_barrier | 1.03091178 |
| 94 | MP0001485_abnormal_pinna_reflex | 1.00516269 |
| 95 | MP0009780_abnormal_chondrocyte_physiolo | 1.00460697 |
| 96 | MP0004924_abnormal_behavior | 1.00436597 |
| 97 | MP0005386_behavior/neurological_phenoty | 1.00436597 |
| 98 | MP0000631_abnormal_neuroendocrine_gland | 0.99180999 |
| 99 | MP0003787_abnormal_imprinting | 0.99152629 |
| 100 | MP0001486_abnormal_startle_reflex | 0.98104235 |
| 101 | MP0005464_abnormal_platelet_physiology | 0.97136928 |
| 102 | MP0003123_paternal_imprinting | 0.95698775 |
| 103 | MP0002063_abnormal_learning/memory/cond | 0.94521242 |
| 104 | MP0002572_abnormal_emotion/affect_behav | 0.94437304 |
| 105 | MP0002932_abnormal_joint_morphology | 0.93233671 |
| 106 | MP0005535_abnormal_body_temperature | 0.92648951 |
| 107 | MP0005385_cardiovascular_system_phenoty | 0.90861413 |
| 108 | MP0001544_abnormal_cardiovascular_syste | 0.90861413 |
| 109 | MP0001348_abnormal_lacrimal_gland | 0.89517847 |
| 110 | MP0004484_altered_response_of | 0.88394564 |
| 111 | MP0003828_pulmonary_edema | 0.88337215 |
| 112 | MP0010386_abnormal_urinary_bladder | 0.87694587 |
| 113 | MP0006138_congestive_heart_failure | 0.87399671 |
| 114 | MP0000013_abnormal_adipose_tissue | 0.87352540 |
| 115 | MP0002163_abnormal_gland_morphology | 0.86599067 |
| 116 | MP0004510_myositis | 0.85828688 |
| 117 | MP0000358_abnormal_cell_content/ | 0.85421871 |
| 118 | MP0010030_abnormal_orbit_morphology | 0.82893848 |
| 119 | MP0003950_abnormal_plasma_membrane | 0.82518953 |
| 120 | MP0005083_abnormal_biliary_tract | 0.82336273 |
| 121 | MP0002396_abnormal_hematopoietic_system | 0.81583754 |
| 122 | MP0002078_abnormal_glucose_homeostasis | 0.80919495 |
| 123 | MP0003195_calcinosis | 0.79895515 |
| 124 | MP0000762_abnormal_tongue_morphology | 0.78427025 |
| 125 | MP0002138_abnormal_hepatobiliary_system | 0.77321146 |
| 126 | MP0004859_abnormal_synaptic_plasticity | 0.75544701 |
| 127 | MP0005379_endocrine/exocrine_gland_phen | 0.74548873 |
| 128 | MP0005410_abnormal_fertilization | 0.73186148 |
| 129 | MP0001849_ear_inflammation | 0.73180810 |
| 130 | MP0000049_abnormal_middle_ear | 0.73101649 |
| 131 | MP0002114_abnormal_axial_skeleton | 0.72920936 |
| 132 | MP0002557_abnormal_social/conspecific_i | 0.72654593 |
| 133 | MP0005319_abnormal_enzyme/_coenzyme | 0.72212702 |
| 134 | MP0005376_homeostasis/metabolism_phenot | 0.70799734 |
| 135 | MP0006072_abnormal_retinal_apoptosis | 0.70421868 |
| 136 | MP0003806_abnormal_nucleotide_metabolis | 0.70033852 |
| 137 | MP0000747_muscle_weakness | 0.69413506 |
| 138 | MP0000350_abnormal_cell_proliferation | 0.69092541 |
| 139 | MP0002693_abnormal_pancreas_physiology | 0.67209244 |
| 140 | MP0001293_anophthalmia | 0.65748317 |
| 141 | MP0009046_muscle_twitch | 0.64073859 |
| 142 | MP0002085_abnormal_embryonic_tissue | 0.64046198 |
| 143 | MP0002132_abnormal_respiratory_system | 0.62975671 |
| 144 | MP0004130_abnormal_muscle_cell | 0.61987832 |
| 145 | MP0000266_abnormal_heart_morphology | 0.61853275 |
| 146 | MP0008770_decreased_survivor_rate | 0.58873320 |
| 147 | MP0002086_abnormal_extraembryonic_tissu | 0.58527530 |
| 148 | MP0002233_abnormal_nose_morphology | 0.57910260 |
| 149 | MP0005452_abnormal_adipose_tissue | 0.57598975 |
| 150 | MP0004142_abnormal_muscle_tone | 0.55261216 |
| 151 | MP0003077_abnormal_cell_cycle | 0.55206863 |
| 152 | MP0004270_analgesia | 0.54965146 |
| 153 | MP0000313_abnormal_cell_death | 0.54023721 |
| 154 | MP0009115_abnormal_fat_cell | 0.51251036 |
| 155 | MP0002909_abnormal_adrenal_gland | 0.50120689 |
| 156 | MP0002925_abnormal_cardiovascular_devel | 0.49337592 |
| 157 | MP0003186_abnormal_redox_activity | 0.48627001 |
| 158 | MP0002752_abnormal_somatic_nervous | 0.47763418 |
| 159 | MP0000428_abnormal_craniofacial_morphol | 0.46085962 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 6.58715515 |
| 2 | Nemaline bodies (HP:0003798) | 6.53651220 |
| 3 | Bilateral microphthalmos (HP:0007633) | 6.53526346 |
| 4 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 6.24513415 |
| 5 | Hypochromic microcytic anemia (HP:0004840) | 5.76583072 |
| 6 | Multiple enchondromatosis (HP:0005701) | 5.22015532 |
| 7 | Exercise-induced muscle cramps (HP:0003710) | 4.75721730 |
| 8 | Hepatoblastoma (HP:0002884) | 4.74267869 |
| 9 | Abnormality of the lower motor neuron (HP:0002366) | 4.29967044 |
| 10 | Ragged-red muscle fibers (HP:0003200) | 4.27885971 |
| 11 | Type 1 muscle fiber predominance (HP:0003803) | 4.16566941 |
| 12 | Increased serum pyruvate (HP:0003542) | 3.97495307 |
| 13 | Abnormality of glycolysis (HP:0004366) | 3.97495307 |
| 14 | Hyperventilation (HP:0002883) | 3.84144699 |
| 15 | Rib fusion (HP:0000902) | 3.69456520 |
| 16 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.67664911 |
| 17 | Hypoplasia of the fovea (HP:0007750) | 3.67664911 |
| 18 | Difficulty running (HP:0009046) | 3.62246851 |
| 19 | Testicular atrophy (HP:0000029) | 3.51175800 |
| 20 | Distal arthrogryposis (HP:0005684) | 3.47251573 |
| 21 | Ventricular tachycardia (HP:0004756) | 3.47051405 |
| 22 | Increased connective tissue (HP:0009025) | 3.23875627 |
| 23 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.22066060 |
| 24 | Ependymoma (HP:0002888) | 3.05596475 |
| 25 | Rimmed vacuoles (HP:0003805) | 3.04993340 |
| 26 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.99354338 |
| 27 | Abnormality of the fovea (HP:0000493) | 2.99139352 |
| 28 | 3-Methylglutaconic aciduria (HP:0003535) | 2.96575741 |
| 29 | Exercise-induced myalgia (HP:0003738) | 2.86456427 |
| 30 | Fetal akinesia sequence (HP:0001989) | 2.85794266 |
| 31 | Progressive muscle weakness (HP:0003323) | 2.84364248 |
| 32 | Neoplasm of striated muscle (HP:0009728) | 2.83170674 |
| 33 | Embryonal renal neoplasm (HP:0011794) | 2.81452145 |
| 34 | Bifid tongue (HP:0010297) | 2.81258207 |
| 35 | Abnormality of the salivary glands (HP:0010286) | 2.78838690 |
| 36 | Myopathic facies (HP:0002058) | 2.78713766 |
| 37 | Myoglobinuria (HP:0002913) | 2.74575833 |
| 38 | Absent phalangeal crease (HP:0006109) | 2.70395731 |
| 39 | EMG: myopathic abnormalities (HP:0003458) | 2.67461456 |
| 40 | Rhabdomyosarcoma (HP:0002859) | 2.67027384 |
| 41 | Acute necrotizing encephalopathy (HP:0006965) | 2.63437576 |
| 42 | Horizontal nystagmus (HP:0000666) | 2.63397505 |
| 43 | Rectal fistula (HP:0100590) | 2.55820120 |
| 44 | Rectovaginal fistula (HP:0000143) | 2.55820120 |
| 45 | Ulnar deviation of the wrist (HP:0003049) | 2.55242165 |
| 46 | Generalized hypotonia (HP:0001290) | 2.55240193 |
| 47 | Anomalous pulmonary venous return (HP:0010772) | 2.54031030 |
| 48 | Type 2 muscle fiber atrophy (HP:0003554) | 2.53122827 |
| 49 | Amyotrophic lateral sclerosis (HP:0007354) | 2.52900741 |
| 50 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.50207005 |
| 51 | Frequent falls (HP:0002359) | 2.49050882 |
| 52 | Bundle branch block (HP:0011710) | 2.48849629 |
| 53 | Partial duplication of thumb phalanx (HP:0009944) | 2.46213860 |
| 54 | Abnormal cartilage morphology (HP:0002763) | 2.46200929 |
| 55 | Progressive macrocephaly (HP:0004481) | 2.46129538 |
| 56 | Reduced antithrombin III activity (HP:0001976) | 2.44627090 |
| 57 | Abnormality of chromosome segregation (HP:0002916) | 2.42551293 |
| 58 | Abnormal lung lobation (HP:0002101) | 2.41650586 |
| 59 | Pancreatic cysts (HP:0001737) | 2.40705590 |
| 60 | Hyporeflexia of lower limbs (HP:0002600) | 2.40590756 |
| 61 | Mitochondrial inheritance (HP:0001427) | 2.40129522 |
| 62 | Preauricular pit (HP:0004467) | 2.39591255 |
| 63 | Periauricular skin pits (HP:0100277) | 2.39591255 |
| 64 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.38322995 |
| 65 | Atrial fibrillation (HP:0005110) | 2.37763439 |
| 66 | Muscle fibrillation (HP:0010546) | 2.35966645 |
| 67 | Abnormal finger flexion creases (HP:0006143) | 2.34607842 |
| 68 | Neck muscle weakness (HP:0000467) | 2.34443801 |
| 69 | Subaortic stenosis (HP:0001682) | 2.34338005 |
| 70 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.34338005 |
| 71 | Progressive external ophthalmoplegia (HP:0000590) | 2.33063821 |
| 72 | Congenital stationary night blindness (HP:0007642) | 2.31670059 |
| 73 | Tongue fasciculations (HP:0001308) | 2.30809431 |
| 74 | Intestinal fistula (HP:0100819) | 2.29688154 |
| 75 | Abnormality of glycolipid metabolism (HP:0010969) | 2.29594716 |
| 76 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.29594716 |
| 77 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.29594716 |
| 78 | Primary atrial arrhythmia (HP:0001692) | 2.28499985 |
| 79 | Microvesicular hepatic steatosis (HP:0001414) | 2.28133038 |
| 80 | Hepatic necrosis (HP:0002605) | 2.27948529 |
| 81 | Medial flaring of the eyebrow (HP:0010747) | 2.27718236 |
| 82 | Sudden death (HP:0001699) | 2.27660562 |
| 83 | Round ear (HP:0100830) | 2.27059811 |
| 84 | Febrile seizures (HP:0002373) | 2.26081971 |
| 85 | Ketoacidosis (HP:0001993) | 2.25893616 |
| 86 | Failure to thrive in infancy (HP:0001531) | 2.23239724 |
| 87 | Supraventricular tachycardia (HP:0004755) | 2.22845780 |
| 88 | Sensory axonal neuropathy (HP:0003390) | 2.21886671 |
| 89 | Abnormality of midbrain morphology (HP:0002418) | 2.21350910 |
| 90 | Molar tooth sign on MRI (HP:0002419) | 2.21350910 |
| 91 | Gout (HP:0001997) | 2.21265475 |
| 92 | Nasolacrimal duct obstruction (HP:0000579) | 2.19829055 |
| 93 | Nephronophthisis (HP:0000090) | 2.19267557 |
| 94 | Fused cervical vertebrae (HP:0002949) | 2.19125652 |
| 95 | Tetraplegia (HP:0002445) | 2.18988087 |
| 96 | EMG: neuropathic changes (HP:0003445) | 2.18817686 |
| 97 | Pancreatic fibrosis (HP:0100732) | 2.18139434 |
| 98 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.16297902 |
| 99 | Fatigable weakness (HP:0003473) | 2.15995990 |
| 100 | Abnormality of the neuromuscular junction (HP:0003398) | 2.15995990 |
| 101 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.15749844 |
| 102 | Acute encephalopathy (HP:0006846) | 2.15739387 |
| 103 | Type II lissencephaly (HP:0007260) | 2.15141127 |
| 104 | Abnormality of the renal cortex (HP:0011035) | 2.15013830 |
| 105 | Vaginal fistula (HP:0004320) | 2.14762685 |
| 106 | Calf muscle hypertrophy (HP:0008981) | 2.14037918 |
| 107 | Renal cortical cysts (HP:0000803) | 2.13611362 |
| 108 | Chromsome breakage (HP:0040012) | 2.12745836 |
| 109 | Supraventricular arrhythmia (HP:0005115) | 2.11855544 |
| 110 | Increased CSF lactate (HP:0002490) | 2.11426785 |
| 111 | Hepatocellular necrosis (HP:0001404) | 2.11267646 |
| 112 | Combined immunodeficiency (HP:0005387) | 2.10735757 |
| 113 | Abnormality of the pubic bones (HP:0003172) | 2.10254692 |
| 114 | Abnormality of the pulmonary veins (HP:0011718) | 2.07382150 |
| 115 | Myotonia (HP:0002486) | 2.05680110 |
| 116 | Hypochromic anemia (HP:0001931) | 2.04277042 |
| 117 | Epileptic encephalopathy (HP:0200134) | 2.02785687 |
| 118 | Ketosis (HP:0001946) | 2.02293769 |
| 119 | Muscle fiber atrophy (HP:0100295) | 2.02175535 |
| 120 | True hermaphroditism (HP:0010459) | 2.02137050 |
| 121 | Partial duplication of the phalanx of hand (HP:0009999) | 2.01539854 |
| 122 | Rhabdomyolysis (HP:0003201) | 2.00426250 |
| 123 | Weak cry (HP:0001612) | 2.00118776 |
| 124 | Neoplasm of the heart (HP:0100544) | 1.99697899 |
| 125 | Muscle fiber splitting (HP:0003555) | 1.99567859 |
| 126 | Trismus (HP:0000211) | 1.99223047 |
| 127 | Methylmalonic acidemia (HP:0002912) | 1.97960107 |
| 128 | Hemiparesis (HP:0001269) | 1.97802972 |
| 129 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.97733483 |
| 130 | Inability to walk (HP:0002540) | 1.97417301 |
| 131 | Increased variability in muscle fiber diameter (HP:0003557) | 1.96399445 |
| 132 | Muscle stiffness (HP:0003552) | 1.96381940 |
| 133 | Skin nodule (HP:0200036) | 1.95610957 |
| 134 | Absent speech (HP:0001344) | 1.94946229 |
| 135 | Polyphagia (HP:0002591) | 1.94628577 |
| 136 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.94173169 |
| 137 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.94114426 |
| 138 | Generalized muscle weakness (HP:0003324) | 1.93504604 |
| 139 | Astrocytoma (HP:0009592) | 1.92932486 |
| 140 | Abnormality of the astrocytes (HP:0100707) | 1.92932486 |
| 141 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.92827064 |
| 142 | Syncope (HP:0001279) | 1.92671803 |
| 143 | Left ventricular hypertrophy (HP:0001712) | 1.91594117 |
| 144 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.91427911 |
| 145 | Abnormality of alanine metabolism (HP:0010916) | 1.91427911 |
| 146 | Hyperalaninemia (HP:0003348) | 1.91427911 |
| 147 | Malignant hyperthermia (HP:0002047) | 1.88090712 |
| 148 | Gait imbalance (HP:0002141) | 1.87379714 |
| 149 | Agitation (HP:0000713) | 1.87144039 |
| 150 | Pachygyria (HP:0001302) | 1.86518276 |
| 151 | Abnormal EKG (HP:0003115) | 1.86349200 |
| 152 | Exercise intolerance (HP:0003546) | 1.86340362 |
| 153 | Angiofibromas (HP:0010615) | 1.86071853 |
| 154 | Adenoma sebaceum (HP:0009720) | 1.86071853 |
| 155 | Dyschromatopsia (HP:0007641) | 1.85845224 |
| 156 | Amblyopia (HP:0000646) | 1.84197441 |
| 157 | Increased intramyocellular lipid droplets (HP:0012240) | 1.83426556 |
| 158 | Stomatitis (HP:0010280) | 1.83028572 |
| 159 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.82495354 |
| 160 | Webbed neck (HP:0000465) | 1.82272169 |
| 161 | Optic disc pallor (HP:0000543) | 1.81836027 |
| 162 | Abnormality of the renal medulla (HP:0100957) | 1.81749812 |
| 163 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.81058422 |
| 164 | Abnormality of the calf musculature (HP:0001430) | 1.80911590 |
| 165 | Shawl scrotum (HP:0000049) | 1.80727106 |
| 166 | Attenuation of retinal blood vessels (HP:0007843) | 1.80596106 |
| 167 | Gowers sign (HP:0003391) | 1.79917004 |
| 168 | Methylmalonic aciduria (HP:0012120) | 1.75448827 |
| 169 | Ventricular fibrillation (HP:0001663) | 1.74862367 |
| 170 | Prolonged QT interval (HP:0001657) | 1.74423815 |
| 171 | Progressive cerebellar ataxia (HP:0002073) | 1.73593116 |
| 172 | Oligomenorrhea (HP:0000876) | 1.72614627 |
| 173 | Paralysis (HP:0003470) | 1.71161201 |
| 174 | Broad-based gait (HP:0002136) | 1.69879871 |
| 175 | Lactic acidosis (HP:0003128) | 1.69479289 |
| 176 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.68737239 |
| 177 | Congenital primary aphakia (HP:0007707) | 1.68272731 |
| 178 | Increased muscle lipid content (HP:0009058) | 1.68227594 |
| 179 | Poor eye contact (HP:0000817) | 1.65962677 |
| 180 | Congenital sensorineural hearing impairment (HP:0008527) | 1.63022860 |
| 181 | Areflexia of lower limbs (HP:0002522) | 1.62553643 |
| 182 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.60236467 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 6.75847076 |
| 2 | GRK5 | 5.61918131 |
| 3 | ERN1 | 4.14083383 |
| 4 | GRK6 | 4.02331729 |
| 5 | ADRBK2 | 3.36035364 |
| 6 | FRK | 3.17776844 |
| 7 | GRK7 | 3.16453862 |
| 8 | GRK1 | 3.10651786 |
| 9 | CSF1R | 2.96877998 |
| 10 | TGFBR2 | 2.63791166 |
| 11 | BMPR1B | 2.49456291 |
| 12 | MAPK7 | 2.37740388 |
| 13 | MARK1 | 2.32127501 |
| 14 | MOS | 2.31485071 |
| 15 | TYRO3 | 2.18036252 |
| 16 | MAP4K2 | 2.06159068 |
| 17 | MATK | 2.05795166 |
| 18 | MAPK13 | 2.04415315 |
| 19 | PIK3CG | 1.96509586 |
| 20 | TTK | 1.93915858 |
| 21 | NEK1 | 1.93602183 |
| 22 | TAOK3 | 1.86121982 |
| 23 | MAP2K4 | 1.83613209 |
| 24 | WNK3 | 1.80795159 |
| 25 | WNK1 | 1.76346020 |
| 26 | OBSCN | 1.67986484 |
| 27 | CAMK4 | 1.66772825 |
| 28 | STK10 | 1.65191705 |
| 29 | PDK3 | 1.63809259 |
| 30 | PDK4 | 1.63809259 |
| 31 | DAPK2 | 1.58889918 |
| 32 | PRKG2 | 1.57526965 |
| 33 | PHKG1 | 1.44686685 |
| 34 | PHKG2 | 1.44686685 |
| 35 | ADRBK1 | 1.39119878 |
| 36 | TXK | 1.34613953 |
| 37 | MAPK12 | 1.31891470 |
| 38 | MARK2 | 1.25390307 |
| 39 | AKT3 | 1.22132806 |
| 40 | TTN | 1.15564605 |
| 41 | NTRK1 | 1.09305272 |
| 42 | PTK2B | 1.09288028 |
| 43 | ACVR1B | 1.08388349 |
| 44 | TRIM28 | 1.05949232 |
| 45 | EPHA3 | 1.00204744 |
| 46 | MAP3K7 | 0.97458837 |
| 47 | CAMKK2 | 0.93321110 |
| 48 | RIPK4 | 0.91800649 |
| 49 | PRPF4B | 0.91351647 |
| 50 | MST4 | 0.90423699 |
| 51 | CDK8 | 0.89609084 |
| 52 | MAP2K6 | 0.89596853 |
| 53 | LATS2 | 0.85861603 |
| 54 | NUAK1 | 0.85313955 |
| 55 | CSNK1G2 | 0.85118006 |
| 56 | CHEK2 | 0.83257314 |
| 57 | TNK2 | 0.82909634 |
| 58 | CDK7 | 0.82865644 |
| 59 | PDK2 | 0.81211082 |
| 60 | CAMK1 | 0.80918144 |
| 61 | OXSR1 | 0.80448786 |
| 62 | SYK | 0.78402954 |
| 63 | FGFR3 | 0.76739536 |
| 64 | PAK4 | 0.76535192 |
| 65 | PINK1 | 0.76516951 |
| 66 | CSNK1G3 | 0.74509785 |
| 67 | PLK2 | 0.74303340 |
| 68 | PKN1 | 0.72139791 |
| 69 | ERBB3 | 0.71879312 |
| 70 | HIPK2 | 0.70020205 |
| 71 | CAMK2A | 0.69866483 |
| 72 | SGK2 | 0.68624809 |
| 73 | AKT2 | 0.67318665 |
| 74 | TEC | 0.67252550 |
| 75 | CSNK1G1 | 0.67055655 |
| 76 | PLK1 | 0.66675341 |
| 77 | WNK4 | 0.62326083 |
| 78 | CAMK2D | 0.61560913 |
| 79 | TRPM7 | 0.60879041 |
| 80 | SGK494 | 0.60735923 |
| 81 | SGK223 | 0.60735923 |
| 82 | INSRR | 0.60379298 |
| 83 | PIK3CA | 0.58083702 |
| 84 | PRKAA1 | 0.57878803 |
| 85 | PRKCE | 0.57694065 |
| 86 | MUSK | 0.57637838 |
| 87 | PRKG1 | 0.57611252 |
| 88 | PAK3 | 0.56674423 |
| 89 | TLK1 | 0.54691573 |
| 90 | MAPKAPK3 | 0.54454183 |
| 91 | CAMK2G | 0.53852013 |
| 92 | MAP2K7 | 0.52479085 |
| 93 | MYLK | 0.51674459 |
| 94 | SGK3 | 0.51519362 |
| 95 | LMTK2 | 0.50151482 |
| 96 | SIK3 | 0.49534205 |
| 97 | CSNK1A1L | 0.49532185 |
| 98 | STK38 | 0.49353132 |
| 99 | TNIK | 0.48313741 |
| 100 | KIT | 0.47860742 |
| 101 | PRKCQ | 0.47417200 |
| 102 | DYRK1B | 0.46722731 |
| 103 | ZAK | 0.46230428 |
| 104 | CDK5 | 0.46093761 |
| 105 | BTK | 0.45720296 |
| 106 | BCKDK | 0.45626477 |
| 107 | CCNB1 | 0.45200909 |
| 108 | TAOK1 | 0.44820678 |
| 109 | PRKCZ | 0.44503370 |
| 110 | NTRK2 | 0.44194851 |
| 111 | CASK | 0.42316377 |
| 112 | MARK3 | 0.41844961 |
| 113 | STK38L | 0.40934407 |
| 114 | LIMK1 | 0.40716685 |
| 115 | FES | 0.40354673 |
| 116 | NTRK3 | 0.38995712 |
| 117 | CAMK2B | 0.38727825 |
| 118 | STK11 | 0.38586293 |
| 119 | STK39 | 0.37862564 |
| 120 | SGK1 | 0.37371916 |
| 121 | PRKCD | 0.37024079 |
| 122 | MAP2K3 | 0.36434372 |
| 123 | DYRK2 | 0.36273584 |
| 124 | CDC7 | 0.36092554 |
| 125 | MAP3K11 | 0.35516456 |
| 126 | CDK19 | 0.34774570 |
| 127 | LYN | 0.34704178 |
| 128 | IRAK1 | 0.34404934 |
| 129 | TAOK2 | 0.34321600 |
| 130 | CHEK1 | 0.33728994 |
| 131 | MAP3K9 | 0.33024934 |
| 132 | PRKACB | 0.32355724 |
| 133 | MAP3K4 | 0.32273847 |
| 134 | IGF1R | 0.31079979 |
| 135 | CDK18 | 0.30933266 |
| 136 | CDK15 | 0.29814786 |
| 137 | PRKCG | 0.28901316 |
| 138 | PAK6 | 0.28777615 |
| 139 | ITK | 0.28564372 |
| 140 | RIPK1 | 0.26769499 |
| 141 | MAP3K6 | 0.26356926 |
| 142 | PRKACA | 0.25962447 |
| 143 | CSK | 0.24397353 |
| 144 | EIF2AK2 | 0.23301364 |
| 145 | STK16 | 0.22972584 |
| 146 | CDK14 | 0.22097386 |
| 147 | PRKACG | 0.22083794 |
| 148 | CDK11A | 0.21929644 |
| 149 | PRKD2 | 0.20785262 |
| 150 | TRIB3 | 0.20414103 |
| 151 | STK24 | 0.20354132 |
| 152 | AURKA | 0.18540269 |
| 153 | ARAF | 0.18512193 |
| 154 | MAPK4 | 0.18080719 |
| 155 | MAP3K12 | 0.17186947 |
| 156 | PAK1 | 0.16864496 |
| 157 | NME1 | 0.15636123 |
| 158 | BRAF | 0.12052589 |
| 159 | ERBB4 | 0.11881815 |
| 160 | MAPK10 | 0.11457975 |
| 161 | CDK2 | 0.09679267 |
| 162 | PDK1 | 0.09586523 |
| 163 | PRKAA2 | 0.09572196 |
| 164 | RPS6KA3 | 0.08003350 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 6.34281680 |
| 2 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 5.15275905 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.45209658 |
| 4 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 4.04290899 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.23745223 |
| 6 | Galactose metabolism_Homo sapiens_hsa00052 | 2.81687497 |
| 7 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.32221002 |
| 8 | Carbon metabolism_Homo sapiens_hsa01200 | 2.25624814 |
| 9 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.22791100 |
| 10 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.19835956 |
| 11 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.17673008 |
| 12 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.16987144 |
| 13 | Phototransduction_Homo sapiens_hsa04744 | 2.13058710 |
| 14 | Circadian rhythm_Homo sapiens_hsa04710 | 1.99217564 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.93065160 |
| 16 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.89775403 |
| 17 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.89051757 |
| 18 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.83167694 |
| 19 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.75494236 |
| 20 | Nicotine addiction_Homo sapiens_hsa05033 | 1.74153714 |
| 21 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.71641782 |
| 22 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.67714515 |
| 23 | Circadian entrainment_Homo sapiens_hsa04713 | 1.64969593 |
| 24 | Morphine addiction_Homo sapiens_hsa05032 | 1.57923881 |
| 25 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.56229873 |
| 26 | Parkinsons disease_Homo sapiens_hsa05012 | 1.55102521 |
| 27 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.54521460 |
| 28 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.52355049 |
| 29 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.49825924 |
| 30 | Insulin secretion_Homo sapiens_hsa04911 | 1.49694312 |
| 31 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.48087438 |
| 32 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.46926014 |
| 33 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.45489190 |
| 34 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.45442009 |
| 35 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.44707253 |
| 36 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.42616612 |
| 37 | Peroxisome_Homo sapiens_hsa04146 | 1.41337790 |
| 38 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.36246222 |
| 39 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.33777215 |
| 40 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.31397035 |
| 41 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.28000662 |
| 42 | Protein export_Homo sapiens_hsa03060 | 1.26963898 |
| 43 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.23201824 |
| 44 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.21732553 |
| 45 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.17140085 |
| 46 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.15971795 |
| 47 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.15181095 |
| 48 | Thyroid cancer_Homo sapiens_hsa05216 | 1.14219174 |
| 49 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.07962456 |
| 50 | Renin secretion_Homo sapiens_hsa04924 | 1.05012580 |
| 51 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.04354469 |
| 52 | Other glycan degradation_Homo sapiens_hsa00511 | 1.04157143 |
| 53 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.03407066 |
| 54 | Olfactory transduction_Homo sapiens_hsa04740 | 1.02089116 |
| 55 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.99125706 |
| 56 | RNA degradation_Homo sapiens_hsa03018 | 0.96413779 |
| 57 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.95861057 |
| 58 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.94683933 |
| 59 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.93001176 |
| 60 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.92746049 |
| 61 | Huntingtons disease_Homo sapiens_hsa05016 | 0.92161155 |
| 62 | Alzheimers disease_Homo sapiens_hsa05010 | 0.90537311 |
| 63 | Salivary secretion_Homo sapiens_hsa04970 | 0.89435792 |
| 64 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.86232044 |
| 65 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.86144837 |
| 66 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.85485917 |
| 67 | Long-term depression_Homo sapiens_hsa04730 | 0.83511459 |
| 68 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.82857213 |
| 69 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.81867771 |
| 70 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.81537605 |
| 71 | Platelet activation_Homo sapiens_hsa04611 | 0.79536614 |
| 72 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.78464357 |
| 73 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.76968389 |
| 74 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.76372395 |
| 75 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.74814369 |
| 76 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.74806671 |
| 77 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.74136501 |
| 78 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.73647454 |
| 79 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.73634044 |
| 80 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.72787242 |
| 81 | Taste transduction_Homo sapiens_hsa04742 | 0.72665932 |
| 82 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.72614392 |
| 83 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.71819779 |
| 84 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.70525372 |
| 85 | Cell cycle_Homo sapiens_hsa04110 | 0.69958806 |
| 86 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.69908606 |
| 87 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.68677515 |
| 88 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.67670939 |
| 89 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.66180214 |
| 90 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64255410 |
| 91 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.62270419 |
| 92 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.61878286 |
| 93 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.61403486 |
| 94 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.61327370 |
| 95 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.60602619 |
| 96 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.59254756 |
| 97 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.58815269 |
| 98 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.57740066 |
| 99 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.57399193 |
| 100 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.57195012 |
| 101 | RNA transport_Homo sapiens_hsa03013 | 0.55950713 |
| 102 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.55490603 |
| 103 | Metabolic pathways_Homo sapiens_hsa01100 | 0.53260471 |
| 104 | GABAergic synapse_Homo sapiens_hsa04727 | 0.52856678 |
| 105 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.52787935 |
| 106 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.52779551 |
| 107 | Cocaine addiction_Homo sapiens_hsa05030 | 0.52718228 |
| 108 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.51775480 |
| 109 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48432776 |
| 110 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.45146887 |
| 111 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.44914966 |
| 112 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.44733929 |
| 113 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.44456431 |
| 114 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.43192881 |
| 115 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.42354685 |
| 116 | Purine metabolism_Homo sapiens_hsa00230 | 0.40743608 |
| 117 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.39205537 |
| 118 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38487051 |
| 119 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.37209720 |
| 120 | ABC transporters_Homo sapiens_hsa02010 | 0.36082769 |
| 121 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.35361013 |
| 122 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.34938839 |
| 123 | Sulfur relay system_Homo sapiens_hsa04122 | 0.33519211 |
| 124 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.32343981 |
| 125 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.30934111 |
| 126 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.30495767 |
| 127 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.30464984 |
| 128 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.30358785 |
| 129 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.30232620 |
| 130 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.29634169 |
| 131 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.28500753 |
| 132 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.28432854 |
| 133 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.27796628 |
| 134 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.24302869 |
| 135 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.23885121 |
| 136 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.23875523 |
| 137 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.22513231 |
| 138 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.22315399 |
| 139 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.21014818 |
| 140 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.20497932 |
| 141 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.19262388 |
| 142 | Insulin resistance_Homo sapiens_hsa04931 | 0.18415868 |
| 143 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.18269910 |
| 144 | Pathways in cancer_Homo sapiens_hsa05200 | 0.17903220 |
| 145 | Basal transcription factors_Homo sapiens_hsa03022 | 0.17406749 |
| 146 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.17239019 |
| 147 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.16053001 |
| 148 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.15948185 |
| 149 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.15755496 |

